T1	Limited_variation	25 39	EGFR mutations
T2	Phenotype	105 126	favorable outcomes in
T3	Disease	150 165	NSCLC receiving
T4	Chemical	166 205	docetaxel plus intercalated erlotinib .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T2	Arg2:T1
R5	isAssociatedWith	Arg1:T3	Arg2:T2
R6	treats	Arg1:T4	Arg2:T1
R7	isAssociatedWith	Arg1:T4	Arg2:T2
R8	treats	Arg1:T4	Arg2:T3
